Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tumescent Steroid Infiltration in Mandibular Third Molar Surgery
NCT07436546Completed
- Sponsor
- Postgraduate Institute of Dental Sciences
- Start
- Mar 2025
- Primary completion
- Dec 2025
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Randomised, double-blind trial of dexamethasone in impacted third molar (I3M) (2 arms), sponsored by Postgraduate Institute of Dental Sciences. Primary endpoint: Postoperative Pain Severity at Day 7. Started Mar 2025; status: completed.
02
Drugs
dexamethasone
03
Conditions
impacted third molar (I3M)
Beyond the preview
Go deeper on NCT07436546.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07436546.